Current therapies in bronchiolitis.
Viral bronchiolitis is the most common cause of hospitalization among infants. Despite its prevalence, no consistently effective therapy has been found to date, providing the driving force behind much of the ongoing research into this illness. In this review, we present a summary of the most recent published trials of interventions for bronchiolitis. Included are studies evaluating bronchodilators, corticosteroids, positive pressure ventilation, as well as 3 newer therapies for bronchiolitis: heliox, mucolytics, and leukotriene receptor antagonists.
Petruzella
Frank D
FD
Division of Emergency Medicine, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA. fpetruze@mcw.edu
Gorelick
Marc H
MH
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D001988:Bronchiolitis / Q000628:therapy*; D001993:Bronchodilator Agents / Q000627:therapeutic use; D045422:Continuous Positive Airway Pressure; D005100:Expectorants / Q000627:therapeutic use; D006371:Helium / Q000627:therapeutic use; D006801:Humans; D020024:Leukotriene Antagonists / Q000627:therapeutic use; D010100:Oxygen / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D001993:Bronchodilator Agents; D005100:Expectorants; D020024:Leukotriene Antagonists; D006371:Helium; C038949:heliox; D010100:Oxygen